Skinvisible, Inc. (SKVI) Partnership with Quoin Focuses on Population’s Pain Needs

• Non-binding proposed merger announced on November 27, 2017


• Quoin merger expected to deliver non-opioid relief to post-surgical patients


• Over-65 population with advanced pain needs expected to double within next 30 years


• Skinvisible and Quoin proposed merger expected to deliver better results to patients

Health professionals are preparing for an expected doubling of the 65 years and older population within the next 30 years, creating medical need to address the pain that often becomes a prevalent companion to age. While modern pharmaceuticals have developed opioids and non-steroidal therapies for reducing chronic pain, the drugs are often accompanied by addiction and unwanted side effect concerns. However, Skinvisible, Inc.’s (OTCQB: SKVI) recently announced non-binding merger with Quoin Pharmaceuticals Limited is creating a partnership that may provide alternative solutions at a time when they are needed the most.

Quoin’s products include QRX001, which will provide 72 hours of effective non-opioid pain relief to post-surgical patients, and QRX002, which is an anticipated once-a-day solution for military PTSD patients at risk for suicidal tendencies. QRX001 will be formulated with an NMDA receptor antagonist that has undergone almost 30 pre-clinical trial studies in the United States. The studies have shown that sub-anesthetic doses of the compound reduced morphine consumption controlled by the patient, as well as post-operative nausea and the reported intensity of pain, while adverse events were reportedly mild or non-existent. QRX001 is anticipated to undergo a phase II trial in the coming year.

Leveraging these results, Skinvisible and Quoin hope to help reduce the abuse of prescription painkillers, which has received classification as a national health emergency (http://dtn.fm/kv1nB). In a recent study reported in JAMA Surgery, 36,000 post-operative patients’ painkiller use was tracked over the course of a half year. The study found that five to six percent of the patients “continued to fill prescriptions for opioids long after what would be considered normal surgical recovery” (http://dtn.fm/R9LgK). In 2016, drug overdose deaths, the majority of them blamed on painkiller dependency, reportedly rose nearly 20 percent over those reported in 2015, according to the New York Times (http://dtn.fm/YUlE7). The Centers for Disease Control and Prevention reported that opioid-related deaths quadrupled between 1999 and 2015 on par with a commensurate increase in the sale of prescription opioids to pharmacies and medical offices during that period (http://dtn.fm/0VSIf).

“Pain is prevalent and often under-treated among older adults,” University of Texas at Arlington researcher Robert Gatchel said in a December statement to MD Magazine (http://dtn.fm/kLd8A). “With 20 percent of Americans expected to be 65 or older by 2030, the development of new and effective pain management strategies is a necessity, especially given that 75 percent of people in this age group have two or more chronic conditions such as heart disease, arthritis or diabetes, which complicate the taking of pain medications.”

The completion of the merger between Skinvisible and Quoin is subject to the negotiation of a definitive agreement and other customary closing conditions, including Quoin completing a financing round for clinical development.

For more information, visit the company’s website at www.Skinvisible.com

Let us hear your thoughts: Skinvisible, Inc. Message Board

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Petrogress, Inc. (PGAS) Sees Opportunities for Energy Expansion, Focusing on Ghana, Cypress and Libya

• For the three months ended September 30, 2017, PGAS reported a profit, greater prepaid expenses and some $3 million added to its assets and shareholder value of the company


• Jim Jimerson, consultant, says in audio interview that PGAS is eyeing more tanker acquisitions and working on worldwide financing, including from the World Bank, for its growth plans


• Diverse revenue stream from oil and gas energy shipping, sales of finished products, a larger tanker fleet and growth through joint ventures

Petrogress, Inc. (OTC: PGAS) sees growth opportunities worldwide for 2018, as this integrated energy company seeks a larger tanker fleet and growth in Ghana, Libya and Cypress. Jim Jimerson, who handles corporate affairs for Petrogress in the U.S., said in an audio interview that the firm, in 2016, consolidated its operations, going public through a reverse merger (http://dtn.fm/JA6kJ). In 2017, it began to show growth through acquisitions and joint ventures internationally. Now, for 2018, it hopes to attract major players as it further expands its production and shipping services.

Jimerson noted that PGAS is focused in 2018 on three priorities. First, the company wishes to consummate a contract in Ghana to give it more growth opportunities. Second, it sees exceptional opportunities for business initiatives to get in on the ground floor in Libya, a location Jimerson describes as being in PGAS’s “wheelhouse” in North Africa. Finally, PGAS is seeking to acquire two more tankers at a discount from Dubai sources, growing its fleet from four to six. This would enable the company to trade through the Suez Canal, boosting its business.

To achieve all that, Jimerson said, the firm is working with U.S. and international finance partners, including the World Bank. In its 3Q2017 SEC 10-Q filing, it reported a profit, adding some $3 million to its book value assets, and increased prepayment on expenses (http://dtn.fm/M4MeD).

PGAS is a New York-based, fully-integrated oil and natural gas energy company with offices in Piraeus, Greece, and Tema, Ghana (located on the west coast of Africa), that manage its operations. PGAS holds various subsidiaries throughout the world. It has a vision of becoming a vertically-integrated energy company. It is segregating its shipping business and petroleum sales into separate companies, which is expected to result in a more focused approach to assist the entities as they pursue individual growth strategies.

The end-goal is to maximize shareholder value. PGAS is divided into four distinct groups: upstream, which consists of oil resources and explosion; midstream, its product fleet carriers; downstream, its refinery and finished product sales; and liquefied, its liquefied natural gas (LNG) sea transportation.

Most recently, PGAS has been expanding its operations to become a greater factor in the oil business and throughout its supply chain. To that end, it has been negotiating partnerships — such as its December 19, 2017, announcement of an MOU signed by its Delaware-based subsidiary, Petrogress Intl. LLC (“PIL”), and EDT Agency Services, Ltd. (EDT Offshore) to combine their operations in certain ports (http://dtn.fm/1qMZr). EDT provides services to oil and gas exploration and production companies globally and operates a fleet of specialized support vessels from numerous facilities. The MOU anticipates a 50-50 partnership between PIL and EDT for certain joint operations.

For more information, visit the company’s website at www.PetrogressInc.com

Let us hear your thoughts: Petrogress, Inc. Message Board

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Skinvisible, Inc. (SKVI) Prepares to Address Killer Drug Epidemic Through Proposed Merger Agreement

Topical and transdermal product development company Skinvisible (OTCQB: SKVI) recently signed a letter of intent regarding a proposed merger with Quoin Pharmaceuticals Limited. The two companies intend to work together to address the opioid epidemic plaguing America. An article discussing this reads: “There are increased incentives and growing public and FDA/government demands to address the crisis. Innovators vying to meet critical needs and to combat the opioid issue with alternative, non-addictive and effective products include Skinvisible, Inc. (OTCQB: SKVI) and Quoin Pharmaceuticals Limited. As announced earlier this month, the two companies have entered a Letter of Intent for a proposed merger, with expected completion in early 2018, that will result in a new entity, Quoin Pharmaceuticals Inc. Upon completion of this merger, the new company (combining Quoin’s strengths of pharmaceutical development and Skinvisible’s innovative technologies that enhance delivery and product performance) has tremendous potential to address the significant needs of the pain management market.”

To view the full article, visit http://dtn.fm/hD7La

Let us hear your thoughts: Skinvisible, Inc. Message Board

About Skinvisible Pharmaceuticals, Inc.

Skinvisible Pharmaceuticals is a research and development company that licenses its proprietary formulations made with Invisicare®, its patented polymer delivery system that offers life-cycle management and unique enhancements for topically delivered products. Invisicare holds active ingredients on the skin for extended periods of time, allowing for the controlled release of actives. For more information, visit the company’s website at www.Skinvisible.com or www.Invisicare.com.

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Marijuana Company of America, Inc. (MCOA) Positioned for Bright Future Amid Support from Recognized Health Organization

With a portfolio of operating subsidiaries, partnerships and joint ventures, Marijuana Company of America (OTC: MCOA) is slated to exploit the ever-growing cannabis market as support of the industry continues to grow among recognized health organizations. An article discussing this reads: “The World Health Organization (“WHO”) officially recommended on December 14, 2017, that the chemical compound cannabidiol (CBD) no longer be internationally scheduled as a controlled substance. WHO has issued a preliminary report that found CBD to be non-addictive and generally safe. … The wholly-owned subsidiary of Marijuana Company of America Inc. (OTC: MCOA), hempSMART™, Inc. is an affiliate marketing company that develops and brings to market hemp-derived cannabinoid-based formulations that are combined with other natural botanicals to create high quality wellness products.”

To read the full article, visit http://dtn.fm/aF78i

Let us hear your thoughts: Marijuana Company of America, Inc. Message Board

About Marijuana Company of America, Inc.

MCOA is a corporation engaged in business including, but not limited to: (1) product research and development of legal hemp-based consumer products containing CBD under the brand name “hempSMART™”, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreations use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop. For more information, visit the company’s website at www.MarijuanaCompanyofAmerica.com.

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) Visits Clinical Trial Facility in San Juan, Puerto Rico

Emerging-stage pharmaceutical and IP development company Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) this morning announced that it has completed a prestudy visit of the Fundación de Investigación (“FDI”) facilities in San Juan, Puerto Rico. Per the release, this will be the site where the company’s research arm, Cannevert Therapeutics Ltd. (“CTL”), will be conducting its first human study of CTL-X, a cannabis strain targeting the pain management market. Speaking about the FDI clinical trial facility in this morning’s update, Veritas CEO Lui Franciosi stated, “I was very impressed by their Phase I and Phase II-III clinical trial units. They were fully staffed and had a complete array of standard medical and laboratory equipment along with a functioning pharmacy… Although the island took a big hit by Hurricane Maria this September, most of San Juan’s major clinical centers such as the FDI suffered little or no damage… We are pleased to see that IMC is fully operational and they are still on track to supply Current Good Manufacturing Practice (“cGMP”) medical cannabis for Cannevert’s upcoming study at FDI.”

To view the full press release, visit http://dtn.fm/q8y2F

Let us hear your thoughts: Veritas Pharma Inc. Message Board

About Veritas Pharma Inc.

Veritas Pharma Inc. is an emerging-stage pharmaceutical and IP development company, who, through its 80% owned Cannevert Therapeutics Ltd. (“CTL”), is advancing the science behind medical cannabis. It is the Company aim, through its investment in CTL, to develop the most effective cannabis strains (cultivars) specific to pain, nausea, epilepsy and PTSD, solving the critical need for clinical data to support medical marijuana claims. CTL’s unique value proposition uses a low-cost research and development model to help drive shareholder value, and speed-to-market. Veritas investment in CTL is led by strong management team, bringing together veteran academic pharmacologists, anesthetists & chemists. The company’s commercial mission is to patent protect CTL’s IP (cultivars & strains) and sell or license to cancer clinics, insurance industry and pharma, targeting multi-billion dollar global markets. For more information, visit the company’s website at www.veritaspharmainc.com

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Petrogress, Inc. (PGAS) is Strengthening Port Operations in Cyprus

• MOU to undertake joint venture in Cyprus port operations


• Set to enter upstream business by operating oil platform


• Gaining eligibility to bid for Ghanaian government contracts

A recent announcement (http://dtn.fm/GtI6w), which also appeared in the Greek media, shows that Petrogress, Inc. (OTC: PGAS) is doubling down in Cyprus. Through subsidiary Petrogress Int’l, LLC (“PIL”), the company has entered into a Memorandum of Understanding (MOU) with EDT Agency Services, Ltd., under which the two companies intend to combine operations at the Port of Limassol. The collaboration also extends to future developments at Vassiliko Energy Port, where the Cyprus Port Authority has announced plans for the construction of a $300 million industrial and energy harbor. The MOU calls for a 50/50 partnership between EDT and PIL, operating under PIL’s PG Cypyard & Offshore Terminal Services unit. The joint venture will provide support services to supply vessels and offshore exploration and production platforms and will help PGAS serve the E&P needs of major international oil companies in the Cyprus Exclusive Economic Zone (EEZ). The partnership is expected to not only boost PGAS’s revenues, but the company’s profile in Limassol and Vassiliko.

EDT provides services to oil and gas exploration and production companies worldwide, and it operates its fleet of specialized support vessels from facilities in Cyprus and Egypt. In 2013, the company established facilities at Limassol to support Houston, Texas-based Noble Energy, Inc.’s Aphrodite and Leviathan Field operations in the Cyprus Exclusive Economic Zone. Its facilities now include a mud plant, heliport services and shore base support for vessels conducting survey, diving, salvage and ROV operations in the Cyprus EEZ and Eastern Mediterranean.

In addition to these developments, Petrogress, Inc. is expanding its footprint in the oil and gas business with ambitious plans in Ghana. Late last year, the company announced that it had acquired 90 percent of the shares of Petrogres Africa Co., Ltd. (“PAF”) through PIL (http://dtn.fm/uUf1y). The remaining 10 percent is privately held by Ghanaian investors. This acquisition creates a wealth of opportunity for PGAS, since, through PAF, the company will be eligible to bid on local Ghanaian government contracts. The PAF deal also goes some way toward turning Petrogress into a vertically integrated petroleum company. PGAS is already heavily involved in the midstream sector. The company, founded in 2009, transports petroleum products with a fleet of tankers based at the historic Port of Piraeus, Greece. It also internationally markets crude oil, distillates and refined products, and it operates service and shipping facilities at the Port of Limassol in Cyprus and the Port of Tema, Greater Accra, in Ghana.

PAF’s value stems from its ability, through Ghanaian government authority, to locally market oil products and conduct shipping business from the Port of Tema. Having access to port facilities in Tema will provide a service and operations hub for PGAS’s tankers currently involved in Nigerian oil trading and transport. The port will also serve as a secondary hub for repair, supply and transport ship operators servicing Ghana’s Tano Basin offshore oil fields in the Gulf of Guinea. Moreover, PAF expects to bid for operating contracts on the currently shut-in APG-1 production platform in the Saltpond Oil Field, which is located in shallow waters approximately eight miles offshore and 65 miles west of Accra. A shut-in platform is one whose output capacity has been set lower than is possible, perhaps for safety reasons.

The project is owned by the Ghana National Oil Company, which is expected to let out its operation by the end of 2017. Preliminary bid terms will require the successful applicant to make repairs on the production platform and work over the six existing wells to boost production from current levels of 300-500 barrels per day (bpd) and will also grant access for exploration and production (E&P) development on up to 10 additional offshore blocks. Current reserve estimates for Saltpond range down to 4.2 million barrels of oil and 20 billion cubic feet of gas recoverable. Unproven reserves on the studied portions of the additional blocks, however, are as high as 44 billion barrels of oil equivalent.

The APG-1 platform, nicknamed “Mr. Louie”, has an interesting history. Dating from the late 1950s, it became the first self-elevating drilling barge classed by the American Bureau of Shipping. It has been employed in the Gulf of Mexico and in the North Sea and has been in West Africa since the late 1970s. After drilling six appraisal wells at the Saltpond Oil Field in offshore Ghana, Mr. Louie was converted into an oil platform at Saltpond in 1978 and renamed, rather more impersonally, as APG-1.

PGAS is also actively seeking opportunities in operating and developing natural gas production and transmission facilities along with LNG processing in the U.S., as well as refinery operations in north and West Africa, and the transport and sales of LNG in Europe.

For more information, visit the company’s website at www.PetrogressInc.com

Let us hear your thoughts: Petrogress, Inc. Message Board

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

ChineseInvestors.com, Inc. (CIIX) CEO Remains Bullish on Bitcoin and Other Cryptocurrencies

• Warren Wang, CEO of CIIX, said in a podcast interview that investors in China and the Chinese-speaking community in the U.S. and Canada want to learn more about bitcoin, cryptocurrencies


• CIIX doubles down on commitment to its bitcoin division, adding a bitcoin ATM in its California headquarters and broadcasting a daily video from the NYSE called ‘Bitcoin Multimillionaire’


• Company’s goal in FY2018 is profit, lower costs and a greater than 100 percent YOY sales increase

ChineseInvestors.com, Inc. (OTCQB: CIIX) CEO Warren Wang remains bullish on the future of bitcoin and other cryptocurrencies, and he recently said in a podcast interview that the Chinese-speaking community worldwide is eager to learn more about buying and managing digital currencies. Despite China’s ban on trading cryptocurrencies on a regulated exchange, he noted, many Chinese investors are buying and selling them on unregulated offline platforms.

In an interview with the Bad Crypto Podcast (http://dtn.fm/0yIgv), Wang explained that the Chinese investor is an important target for cryptocurrency entrepreneurs. “The Chinese investor is an advocate of gambling,” he explained. “Most today trade bitcoin and other cryptocurrencies on the offline market. The Chinese-speaking people within China and also in North America — the U.S. and Canada — are excited about bitcoin.”

CIIX recently hosted and installed a Bitcoin ATM in the lobby of its San Gabriel, California, headquarters (http://dtn.fm/4YznC). Wang called it the first ever by a Chinese company in the U.S. The company also recently attended a Toronto cryptocurrency roadshow and educational seminar on how to buy, sell and manage these coins, he noted in the interview. CIIX has doubled down on its commitment to bitcoin. It produces a daily video from the NYSE called ‘Bitcoin Multimillionaire’ focused on news of the currency (http://dtn.fm/XdX7l).

The company addresses Chinese-speaking audiences worldwide on the subject of investing in bitcoin and other cryptocurrencies, and now, with the ATM, it is actively involved in their trade. Wang has set the goals for CIIX in FY2018 as profitability, lower costs and greater than 100 percent year-over-year revenue growth (http://dtn.fm/fVro3).

Wang said that despite the lack of a regulated Chinese exchange to trade cryptocurrencies and the Chinese government’s ”badmouthing” of bitcoin though its official TV media outlet, there is a great desire by the Chinese-speaking people within China and North America to buy, sell and trade bitcoin.

“Real estate is very expensive and so are labor and rents in China,” he said. “Investors have a high savings rate. They now would like to make bitcoin and other cryptocurrencies part of their assets. They are trading offline on platforms of decentralized exchanges to do so.”

He advised entrepreneurs within the industry to be patient while the Chinese investment community learns about issues like the digital wallets used for buying, selling and managing bitcoin. “The average Chinese investor may have up to $5,000 to invest in these currencies,” he said. “But be patient.”

Wang said that, in the future, China may organize a regulated market for the trading of cryptocurrencies in order to keep monies involved in that trading within China. “But, until now, this has not happened,” he concluded.

For more information, visit the company’s website at www.ChineseInvestors.com

Let us hear your thoughts: ChineseInvestors.com, Inc. Message Board

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Skinvisible, Inc. (SKVI) and Quoin Poised to Tackle Opioid Crisis with Alternative Pain Therapies

- A possible larger role for leading drug manufacturers, and the resulting opioid epidemic, is met with increased public and government demands for alternative therapies
- The Skinvisible and Quoin merger, with expected completion in 2018, will create an enterprise positioned to disrupt the $6 billion U.S. opioid market by producing and delivering non-opioid alternatives for pain management
- Quoin’s QRX001 is slated to provide alternative and effective pain management in the post-surgical setting, where 50 percent of opioid addictions start

A recent article by the Washington Post (http://dtn.fm/cGzr2) addressed the opioid crisis, suggesting a larger role by leading pharmaceutical drug manufacturers than originally thought. The story alludes to the possibility that “drug manufacturers and distributors turned a willfully blind eye toward illegal drug trafficking.” In the midst of this, there is an opioid epidemic that has been deemed a national health emergency that results in 90 deaths per day (http://dtn.fm/JwiX6) and is growing exponentially, according to the Centers for Disease Control and Prevention.

There are increased incentives and growing public and FDA/government demands to address the crisis. Innovators vying to meet critical needs and to combat the opioid issue with alternative, non-addictive and effective products include Skinvisible, Inc. (OTCQB: SKVI) and Quoin Pharmaceuticals Limited. As announced earlier this month, the two companies have entered a Letter of Intent for a proposed merger, with expected completion in early 2018, that will result in a new entity, Quoin Pharmaceuticals Inc. Upon completion of this merger, the new company (combining Quoin’s strengths of pharmaceutical development and Skinvisible’s innovative technologies that enhance delivery and product performance) has tremendous potential to address the significant needs of the pain management market.

One of the main areas of Quoin’s focus is to disrupt the opioid market (currently estimated at $6 billion annually in the U.S. alone) and produce and deliver to market non-opioid products that serve as effective and viable alternatives for the immense pain management market. This focus will include all areas of pain management, including critical needs in the post-surgical setting. At least 50 million U.S. surgeries require the use of post-operative pain management pharmaceuticals annually, and it is in the post-surgical setting that about 50 percent of opioid addictions begin.

To address the critical demands for effective alternatives to opioids, Quoin will launch one of its first lead products, QRX001, for effective treatment of post-surgical pain. The product, a transdermal NMDA receptor antagonist, delivers up to 72 hours of effective post-surgical pain relief. With the aim of providing alternatives to opioids as well as opiates, numerous clinical studies on QRX001 have shown that sub-anesthetic doses have resulted in a marked 24-hour reduction in PCA morphine consumption. In addition, clinical tests of the NMDA receptor antagonist generated superior results to any single existing product or combination and resulted in mild or absent adverse events, reduced post-surgical nausea and vomiting and reduced pain intensity.

With completion of the merger of Skinvisible and Quoin expected in early 2018, the synergies of the merged technologies, expertise and proven track records poise the new Quoin Pharmaceuticals with tremendous potential to address the needs of the immense pain market and tackle the opioid epidemic head-on.

For more information, visit the company’s website at www.Skinvisible.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Petrogress, Inc. (PGAS) Finds New Life in Oil Shipping Markets

Petrogress, Inc. (OTC: PGAS) continues to build a diversified revenue stream through its oil and gas shipping networks as it expands its operations along Africa’s west coast, in the Mediterranean region, Europe and the United States. The company is working to purchase more tankers, complete exploration and refinery talks in Ghana, and finalize negotiations on an operations and management pact in Hellenic Cyprus. An article discussing this reads: “Despite a recent slump in African crude oil sales (http://dtn.fm/Czx2E) and the comparable effect on the company’s sales volume revenues and gross profits, Petrogress reported a rise in profitability from 3.82 percent to 13.14 percent with a record adjusted report of earnings before interest, taxation, depreciation and amortization (EBITDA) of just over $2 million at nine months’ end. Total assets grew during the period from $9.79 million to $14.03 million. ‘We are generating strong operational and financial results in spite to the adverse oil market pricing,’ … Petrogress President and CEO Christos P. Traios stated.”

To view the full article, visit http://dtn.fm/6Gm2B

About Petrogress, Inc.

Petrogress, Inc. owns and operates a fleet of tankers from its base in the historic Port of Piraeus through a series of Marshall Islands subsidiaries.  Its principal and CEO, Christos P. Traios, has over 30 years of experience in operating and managing shipping operations from Greece.  Currently, the Company’s ships trade off the coast of West Africa, transporting crude oil, distillates and refined products.  The Company also operates service and shipping facilities at the Port of Limassol in Cyprus and the Port of Tema, Greater Accra, in Ghana.  It is actively seeking expansion opportunities, including in operating and developing natural gas production and transmission facilities along with LNG processing in the U.S., refinery operations in north and West Africa, and the transport and sales of LNG in Europe. For more information, visit www.PetrogressInc.com.

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Tapinator, Inc. (TAPM) Keeps Pace with Ongoing Growth in Mobile Gaming Market

Through a portfolio of 300-plus mobile games drawing more than 450 million players, New York City-based Tapinator (OTCQB: TAPM) is successfully growing its proprietary processes to generate profits in the gaming industry. An article discussing this reads: “What makes TAPM unique is that it focuses on a quantitive approach to generating shareholder value, instead of beginning the game development process with an emphasis on creative alone. Ilya Nikolayev, Tapinator’s founder and CEO, said that TAPM prioritizes games with higher player retention and projected profitability, keeping an eye toward the metrics that show a game can profitably acquire new players. The company applies a pragmatic, profit-oriented strategy.”

To view the full article, visit http://dtn.fm/02O7v

About TapinatorTapinator develops and publishes mobile games on the iOS, Google Play, and Amazon platforms. Tapinator’s portfolio includes over 300 mobile gaming titles that, collectively, have achieved over 400 million player downloads, including games such as ROCKY™, Video Poker Classic, Solitaire Dash, and Dice Mage. Tapinator generates revenues through the sale of branded advertisements and via consumer app store transactions. Founded in 2013, Tapinator is headquartered in New York, with product development teams located in the United States, Germany, Pakistan, Indonesia, Russia and Canada. For more information, visit the company’s website at www.Tapinator.com.

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – AppSwarm, Inc. (SWRM) Has Finger on Pulse of Burgeoning Mobile Gaming Industry

As gaming, and mobile gaming in particular, approaches an expected $110 billion in revenues worldwide this year, developer and publisher AppSwarm (OTC: SWRM) is working to incubate new talent as it acquires apps for all mobile devices. The company also announced the development of a joint roll-out of mobile applications for the purchase of cannabis using bitcoin payment options and blockchain technology, in conjunction with SinglePoint, Inc. (OTC: SING). Article discussing this reads: “The global gaming industry is expected to grow by almost eight percent over 2016 and to generate a total of approximately $110 billion in revenues this year, from 2.2 billion games worldwide, according to Newzoo’s Global Games Market Report released in April 2017 (http://dtn.fm/Ki1fA). The largest market is in the Asia-Pacific region, with China generating a quarter of all revenues in 2017. Newzoo predicts that this industry will show a compound annual growth rate (CAGR) of 6.2 percent to reach $128.5 billion by 2020. Furthermore, the report forecasts that mobile gaming will generate 42 percent of gaming revenues worldwide.”

To view the full article, visit http://dtn.fm/y3MH1

About AppSwarm

AppSwarm develops and publishes mobile gaming apps, with a focus on accelerating the development of free to play mobile games and fast-track them to market. The company partners with game developers through joint ventures, royalty agreements, marketing partnerships, and outright purchases through its publicly-traded company on the OTC Markets, ticker SWRM. For more information, visit www.App-Swarm.com.

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) Subsidiary Receives Dealer License from Health Canada

Emerging-stage pharmaceutical and IP development company Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) this morning announced that Health Canada has issued its research and development subsidiary, Cannevert Therapeutics Ltd. (“CTL”), a dealer license allowing it to possess, analyze, sale, send, transport and deliver cannabis, hemp and related products. Per the release, reception of this license marks a “significant step” for CTL as it seeks to discover and develop new therapeutic cannabis strains while also providing commercial chemical and biological testing services for licensed producers under Health Canada guidelines. “We are excited that Cannevert scientists will now not only be able to obtain a variety of cannabis strains and related products from multiple licensed producers in Canada, but also from around the world with an acquired import permit,” Dr. Lui Franciosi, CEO of Veritas, stated in the news release. In connection with this morning’s announcement, the company aims to have a full contract service laboratory operating in the latter half of 2018.

To view the full press release, visit http://dtn.fm/ISu3b

About Veritas Pharma Inc.

Veritas Pharma Inc. is an emerging-stage pharmaceutical and IP development company, who, through its 80% owned Cannevert Therapeutics Ltd. (“CTL”), is advancing the science behind medical cannabis. It is the Company aim, through its investment in CTL, to develop the most effective cannabis strains (cultivars) specific to pain, nausea, epilepsy and PTSD, solving the critical need for clinical data to support medical marijuana claims. CTL’s unique value proposition uses a low-cost research and development model to help drive shareholder value, and speed-to-market. Veritas investment in CTL is led by strong management team, bringing together veteran academic pharmacologists, anesthetists & chemists. The company’s commercial mission is to patent protect CTL’s IP (cultivars & strains) and sell or license to cancer clinics, insurance industry and pharma, targeting multi-billion dollar global markets. For more information, visit the company’s website at www.veritaspharmainc.com

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php